Drug Eluting Stents Market by Revenue, Present Scenario and Growth Prospects To 2026

Drug eluting stents are small expandable tubes made of wire that are inserted into the coronary arteries of patients with atherosclerosis. Stent helps to hold the artery open to release a drug that prevents blockage occurring in artery and improves the blood flow. This stent placement are generally carried out in the procedure of coronary angioplasty. The drug eluting stents types are bare metal coronary artery stents, coronary artery restenosis, coronary artery stents, coronary revascularization, paclitaxel eluting coronary artery stents, sirolimus eluting coronary artery stents, target vessel revascularization. Drug eluting stents mostly consist of 3 parts the sent platform, polymer coating which has 1 to 3 layers of polymers cane be coated and the drug is the mainly to inhabit  neointimal growth.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/566

Continuous rise in cardiovascular disease cases is expected to support the demand of drug eluting stents which in turn support the growth for drug eluting stents market in near future. Unhealthy dietary habits, lack of exercise, sedentary lifestyles are the major factors resulting in increased prevalence of cardiovascular disease. According to the World Health Organization (WHO) it was estimated in 2015 around 17.7 million people died from CVDs globally among this death around 7.4 million were coronary heart disease and 6.7 million were due to heart stroke.

Market Dynamics

Rise in  incidence of cardiovascular disease, heart failure  and coronary heart disease cases due to increase in the prevalence of diabetes, obesity, high blood pressure worldwide is expected to favor the demand for drug eluting stents around the globe.
According to the American Heart Association the number of adults living with heart failure were increased around 5.7 million during the year 2009-2012 and was increased around 6.5 million in the year 2011-2014. Currently the number of people with weak heart or with heart failure is projected to rise around 46% by 2030.
Also, increase in obese population and rise in demand for minimally invasive procedures are the other factors leading to the growth of drug eluting stents market in developed as well as emerging economies. According to the National Center for Health Statistics (NCHS), in the U.S. the prevalence of obese was around 36% in adult’s and17% in youth in the year 2011–2014.

Market Taxonomy

This report segments the global drug eluting stents market on the basis of application type, product type and geography. On the basis of product type, the market is categorized into polymer-based coatings and polymer free coatings. Among these, the polymer-based coating segment dominate the drug eluting stents market throughout the forecast period. On the basis of application type the market is segmented into coronary artery diseases and peripheral artery diseases. Among these coronary artery diseases type the holds the largest market share throughout the forecast period. On the basis of geography, the market is divided into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Among all regions, North America contributes major market share supported by increased incidence rate of cardiovascular disease and growing inclination of the populace towards minimally invasive procedures.

Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/market-insight/drug-eluting-stents-market-566

The major key players of drug eluting stents market are Boston Scientific Corporation, Medtronic, Inc., Abbott Laboratories, Biosensors International Group, Biotronik, Lepu Medical Technology, Terumo Medical Corporation, Cook Medical, Shandong JW Medical Systems, Stentys, Abbott Vascular Inc., AlviMedica Medical Technologies Inc., Amaranth Medical, Inc., HangZhou HuaAn Biotechnology Co.,Ltd, XTENT, Inc., CARDIONOVUM GmbH, Cordis Corporation KYOTO MEDICAL PLANNING Co., Ltd.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.